ARCHIVES

Increased Lung Cancer Risk After Hodgkin’s Treatment

This article is from The Cancer Letter archive.

Vol. 25 No. 2 | February 22, 2002

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Support Contract Recompetition

July 6, 1990

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

In Brief Yale Cancer Center Begins Reorganization, Names New Deputy Director, Prevention Chief

January 6, 1995

Politics, Short Tempers, Grievances Dominate NIH Panel On Unconventional Medical Practices

September 25, 1992

Maryland to Use $1B In Tobacco Funds For Cancer Research, Anti-Smoking Program

June 4, 1999

NCI Plans Conference On DES Late Effects, Reproductive Cancers

November 29, 1991